Inhalants withdrawal

Inhalants withdrawal occurs when a person who has been regularly using inhaled substances suddenly stops or reduces their use. These substances affect the central nervous system, causing changes in brain chemistry that lead to physical and psychological dependence. When inhalant use is stopped, the body reacts with symptoms such as anxiety, irritability, and fatigue. Other common effects include nausea, tremors, and difficulty concentrating. This condition primarily impacts the brain and nervous system, disrupting normal function and causing distressing withdrawal symptoms.

Inhalants withdrawal is a syndrome characterized by a cluster of physical and psychological symptoms that arise after abrupt cessation or reduction of chronic inhalant use. The core pathology involves neurochemical imbalances in the central nervous system, particularly affecting GABAergic and dopaminergic pathways. It is usually caused by dependence on volatile substances such as toluene, nitrous oxide, or other hydrocarbons. Clinically, it manifests with symptoms including anxiety, restlessness, tremors, nausea, and sometimes seizures or delirium in severe cases. The condition is significant due to its potential to cause serious complications and the challenge it poses in management due to the lack of standardized treatment protocols.